http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101634440-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-51 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30 |
| filingDate | 2014-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101634440-B1 |
| titleOfInvention | Pharmaceutical Composition Comprising Inhibitors of Phosphorylation of GluA1 Subunit of AMPA receptor for preventing or treating mental disorders |
| abstract | The present invention provides pharmaceutical compositions and screening methods for the prevention or treatment of mental illness comprising an inhibitor of phosphorylation of the 831st serine of GluA1 at the AMPA receptor. The composition according to the present invention can prevent / treat various mental diseases related to the abnormal activity of AMPA receptor by directly controlling AMPA receptor activity through specific inhibition of phosphorylation of Ser831 residue of GluA1 subunit of AMPAR, Can be usefully used for inhibition. |
| priorityDate | 2014-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 112.